OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Genetic studies have the potential to uncover new knowledge on the causes of disease, as well as help understand their complexity through identifying ‘sub-types’ that are underpinned by different pathways of pathogenesis. This information is crucial to inform the identification of novel targets for treatment, as well as methods of (non-invasive) diagnosis. I shall discuss recent progress in the field of endometriosis, covering our collaborative work within the International Endometriosis Genome Consortium, in which we are currently analysing 25 global datasets including >60,000 cases, detailed deep phenotype and comorbidity data, as well as functional ‘omics’ analyses. I will also discuss recent studies of somatic genetic mutations in endometriosis tissue which have received much ‘press’. Lastly, I will discuss how we can translate these genetic results into outcomes that are important to patients and clinicians.
